Company / EPS (Diluted)
Avantor EPS (Diluted) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.47
FY2025
5-year range
$0.09 / $1.01
FY2021-FY2025
Trend
-53.5%
vs FY2024
Sector context
#85 of 159
Health Care
What the data says
At $0.47, Avantor's eps (diluted) ranks #85 of 159 in the Health Care sector. EPS (Diluted) has fluctuated over the past 8 years, ranging from $-2.69 in FY2018 to $1.01 in FY2024.
Based on SEC 10-K filings.
0.47 in FY2025 with a 3-year CAGR of +73.5%.
Declined from $0.85 to $0.47 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +73.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#85 of 159 in Health CareTop 53% of 159This company $0.47 Sector average $1.67
▼
-71.8% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 53.5% year-over-year.
- Ranks #85 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2024.
- Lowest eps (diluted) in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.47 | -53.5% |
| FY2024 | $1.01 | +18.8% |
| FY2023 | $0.85 | +844.4% |
| FY2022 | $0.09 | -89.4% |
| FY2021 | $0.85 | +201.2% |
| FY2020 | -$0.84 | -42.4% |
| FY2019 | -$0.59 | +78.1% |
| FY2018 | -$2.69 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026